March 2013 Newsletter
Highlights of this newsletter include:
- Chief Scientific Officer Ed Ashton answers the question: Are there any special concerns related to imaging in trials of immunotherapeutic agents?
- Chief Technical Officer Jon Riek explores: Body composition imaging using DXA, MRI & CT.
- Radiologist Spotlight - Staff radiologist Jayant Narang, MBBS, MD is again featured with a recently published paper entitled, "Prognostic Vascular Imaging in High-Grade Gliomas: Tumor Permeability as an Adjunct to Blood Volume Estimates."
- VS & PPD to co-present at Strategic Alliance Management Congress in May - Michael Young, VP Alliance Management, PPD and Debra Vent, Director, Business Development VS will co-present "Service-Based Alliance in the Drug Development Industry: Are You Getting Accretive Value from Collaboration?"
Please read more at March 2013 Newsletter
